Compare ORC & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORC | IRMD |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 910.4M |
| IPO Year | 2013 | 2014 |
| Metric | ORC | IRMD |
|---|---|---|
| Price | $7.21 | $97.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $7.50 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 6.0M | 77.1K |
| Earning Date | 01-29-2026 | 02-12-2026 |
| Dividend Yield | ★ 19.78% | 0.70% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | 0.57 | ★ 1.65 |
| Revenue | $80,187,000.00 | ★ $80,511,268.00 |
| Revenue This Year | $90.64 | $15.17 |
| Revenue Next Year | $78.88 | $10.15 |
| P/E Ratio | ★ $12.69 | $59.26 |
| Revenue Growth | 5.93 | ★ 12.91 |
| 52 Week Low | $5.69 | $47.48 |
| 52 Week High | $9.01 | $98.53 |
| Indicator | ORC | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 45.63 | 65.76 |
| Support Level | $7.28 | $90.92 |
| Resistance Level | $7.40 | $98.53 |
| Average True Range (ATR) | 0.12 | 2.27 |
| MACD | -0.00 | -0.41 |
| Stochastic Oscillator | 27.72 | 85.81 |
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.